Scleromyxedema.
D003165:Complement System Proteins / Q000032:analysis; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy* / Q000276:immunology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use
D005446:Fluocinolone Acetonide; D006118:Griseofulvin; D003165:Complement System Proteins; D014222:Triamcinolone Acetonide